Nexalin Technology Stock Current Valuation
| NXLIW Stock | USD 0.62 0.21 51.22% |
Valuation analysis of Nexalin Technology helps investors to measure Nexalin Technology's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Enterprise Value Over EBITDA is likely to drop to -0.44 in 2024. Enterprise Value Multiple is likely to drop to -0.44 in 2024.
Overvalued
Today
Please note that Nexalin Technology's price fluctuation is out of control at this time. Calculation of the real value of Nexalin Technology is based on 3 months time horizon. Increasing Nexalin Technology's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Nexalin stock is determined by what a typical buyer is willing to pay for full or partial control of Nexalin Technology. Since Nexalin Technology is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Nexalin Stock. However, Nexalin Technology's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.62 | Real 0.42 | Hype 0.69 | Naive 0.53 |
The intrinsic value of Nexalin Technology's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Nexalin Technology's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Nexalin Technology helps investors to forecast how Nexalin stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Nexalin Technology more accurately as focusing exclusively on Nexalin Technology's fundamentals will not take into account other important factors: Nexalin Technology Company Current Valuation Analysis
Nexalin Technology's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Nexalin Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Nexalin Technology is extremely important. It helps to project a fair market value of Nexalin Stock properly, considering its historical fundamentals such as Current Valuation. Since Nexalin Technology's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Nexalin Technology's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Nexalin Technology's interrelated accounts and indicators.
Click cells to compare fundamentals
Nexalin Current Valuation Historical Pattern
Today, most investors in Nexalin Technology Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Nexalin Technology's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Nexalin Technology current valuation as a starting point in their analysis.
Nexalin Technology Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Nexalin Technology has a Current Valuation of 0.0. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and 100.0% lower than that of the Health Care industry. The current valuation for all United States stocks is 100.0% higher than that of the company.
Nexalin Technology is currently under evaluation in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is now estimated at about 0.0. Nexalin Technology adds roughly 0.0 in current valuation claiming only tiny portion of equities under Health Care industry.Nexalin Fundamentals
| Return On Equity | -2.02 | ||||
| Return On Asset | -1.19 | ||||
| Operating Margin | (48.32) % | ||||
| Number Of Shares Shorted | 3.97 K | ||||
| Revenue | 110.75 K | ||||
| EBITDA | (5.69 M) | ||||
| Net Income | (4.65 M) | ||||
| Total Debt | 4.46 K | ||||
| Book Value Per Share | 0.43 X | ||||
| Cash Flow From Operations | (3.84 M) | ||||
| Beta | 3.57 | ||||
| Total Asset | 3.63 M | ||||
| Retained Earnings | (77.04 M) | ||||
| Working Capital | 3 M | ||||
| Net Asset | 3.63 M |
About Nexalin Technology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nexalin Technology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nexalin Technology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nexalin Technology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Nexalin Stock Analysis
When running Nexalin Technology's price analysis, check to measure Nexalin Technology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nexalin Technology is operating at the current time. Most of Nexalin Technology's value examination focuses on studying past and present price action to predict the probability of Nexalin Technology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nexalin Technology's price. Additionally, you may evaluate how the addition of Nexalin Technology to your portfolios can decrease your overall portfolio volatility.